FDA Approves Lilly’s New Oral Combo Pill for Common Breast Cancer Mutation
Healthline · 2h ago
Untick a publication to hide it. Your choices stay in this browser. Journals, preprints, consumer brands and other high-volume feeds are off until you turn them on.
Medicine & Biotech · covered by 17 outlets this week · tracked since 2026-10-27
Press: 12 mainstream 20 specialist 5 independent outlet-days